ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Hep-B vaccine four-year battle for FDA approval is finally won
pharmafile
November 13, 2017Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data pointed to it entering the market as best-in-class but it had received one knock-back after another, culminating in a final three month user fee action d
Pharma Sources Insight January 2025
